PROCAPAN Drug Patent Profile
✉ Email this page to a colleague
When do Procapan patents expire, and what generic alternatives are available?
Procapan is a drug marketed by Panray and is included in one NDA.
The generic ingredient in PROCAPAN is procainamide hydrochloride. There are nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the procainamide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Procapan
A generic version of PROCAPAN was approved as procainamide hydrochloride by INTL MEDICATION on July 31st, 1984.
Summary for PROCAPAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 119 |
Patent Applications: | 1,256 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROCAPAN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PROCAPAN
US Patents and Regulatory Information for PROCAPAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Panray | PROCAPAN | procainamide hydrochloride | CAPSULE;ORAL | 083553-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |